HEALTH● LOWSep 14 · Sep 14, 2026, 3:58 PM
Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety
Seeking Alpha Tech · global
Definium's stock rose following the successful achievement of primary goals in a late-stage clinical trial for an LSD pill designed to treat anxiety. This indicates progress in psychedelic-assisted therapy research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoA tale of two emergencies: Why Nigeria does not need new science, By Adewale AdeyemoPremium TimesHEALTH2h agoAttappady tribal hospital to get more specialists, newborn care facilitiesThe HinduHEALTH2h agoMore than 5,000 people die from Ebola in the deadliest epidemic the Democratic Republic of Congo has ever knownBBC AfriqueHEALTH3h agoWhy are so many young Americans dying?The Hill